Search results

Collaboration finds that old carbon reservoirs are unlikely to cause a massive greenhouse gas release in a warming world.

Sample environments, Data Analysis, Mail-in Services.

ANSTO environmental scientists contribute to investigation of carbon capture in wetlands.

ANSTO's reactor utilisation team has received an international award.

ANSTO today welcomed a significant Federal Government funding allocation to further safeguard the production of life-saving nuclear medicines in Australia.

ANSTO’s Radioanalytical Chemistry (RAC) facility combines techniques in radiochemistry and radiological measurement by alpha spectrometry, gamma-ray spectrometry, and liquid scintillation analysis to deliver radiological assessments.

Macromolecular crystallography helps determine the atomic structure.

ANSTO scientists have been featured in the new issue of Careers with STEM Science, a publication produced for high school students, undergraduates and grads, careers advisors, teachers and parents to discover careers and study paths.

ANSTO is coordinating and facilitating the calling of pre-concept papers for the next cycle of technical cooperative project proposals under the Regional Cooperative Agreement for Research, Development and Training Related to Nuclear Science and Technology for Asia and the Pacific (RCA) | IAEA

New screening method developed to confirm if deuteration improves metabolic stability.

Phenomenon predicted by Nobel Prize recipient

The need for a smaller, more transportable version of ANSTO’s 1500-litre atmospheric radon-222 monitor, and with a calibration traceable to the International System of Units, prompted the team to develop a 200-litre radon monitor that would meet those needs.

Combined imaging approach characterises plaques associated with disease.

Using nuclear techniques to help sustain Australia's finite groundwater resources

Scandium 47, a therapeutic radioisotope and potential theranostic, has been produced for the first time at ANSTO. Theranostics are used to both diagnose and treat disease.

A special inaugural event held by ANSTO at its Australian Synchrotron for more than 30 funding organisations has showcased the first of the $100 million BRIGHT Program’s brand new, state-of-the-art beamlines.